Sign in

Thomas Reiser

@tomreiser.bsky.social
285 followers 110 following 234 posts

International association executive and world traveler. Opinions are my own. Retweets do not imply endorsement.

PostsRepliesMedia
Thomas Reiser @tomreiser.bsky.social · 20/12/2025
In case you missed it and are wondering where @isth.org #ISTH2027 will be held: 🇨🇦 VANCOUVER 🇨🇦! Under the leadership of ACPC Chair @marccarriermd.bsky.social Mark your calendars already for June 26-30, 2027. Read more at: bit.ly/4iJznfy
064
Thomas Reiser @tomreiser.bsky.social · 19/12/2025
Today is my final day as Executive Director of @ISTH.org. After 14+ years, I leave with deep gratitude for the trust, friendships, and shared commitment to a mission and organization I believe in so deeply. Thank you for the impact we have created together.❤️ Stay tuned for what comes next! 🙂
031
Thomas Reiser @tomreiser.bsky.social · 19/12/2025
In this season of giving, please consider supporting the important work of the @ISTH.org with a donation. 🎁 Your gift makes a difference & greatly supports the advancement of #thrombosis & #hemostasis knowledge, education & care worldwide. Thank you! 🙏 www.isth.org/donations ⬇️
021
Thomas Reiser @tomreiser.bsky.social · 18/12/2025
Are you still looking for a great 🎁for yourself or someone else interested in #thrombosis & #hemostasis? 💡Gift an @ISTH.org membership & enjoy the benefits & network of the largest global medical-scientific org & community in bleeding & clotting disorders! ✍️https://www.isth.org/page/Membership
021
Thomas Reiser @tomreiser.bsky.social · 17/12/2025
💡Are you interested in Structural bioinformatics for drug discovery in #thrombosis & #hemostasis & biomolecular modeling for translational research? Don't miss the first @ISTH.org webinar of 2026! 🗓️January 29 @ 15:00 UTC. Speakers 🎙️Kanin Wichapong 🇳🇱 🎙️Karin Leiderman 🇺🇸 bit.ly/44T95Su
021
Thomas Reiser @tomreiser.bsky.social · 16/12/2025
💡Before you go into the year-end holidays, make plans to finalize and submit your best work for presentation at @ISTH.org #ISTH2026 🗓️Abstract Deadline is February 2, 2026! ✍️isthcongress.org/abstracts #ISTHRoadToParis
021
Thomas Reiser @tomreiser.bsky.social · 15/12/2025
💡Your expertise is requested! Public comment on the @ISTH.org #SSC Guidance on ✅"How to Monitor and Manage Unfractionated Heparin in Practice" is now open. ✍️Review and submit your comments by January 5 bit.ly/48WR4Ei
021
Thomas Reiser @tomreiser.bsky.social · 14/12/2025
So proud to share the @ISTH.org 2025 @worldthrombosisday.bsky.social Impact Report! Learn about the lives reached, awareness raised, activities & impact on preventing #bloodclots globally. Thank you to our partners, supporters & community who drive change every day. tinyurl.com/yzknecsy #WTDay25
020
Thomas Reiser @tomreiser.bsky.social · 13/12/2025
💡In case you need another reason to submit your abstracts and plan to attend @isth.org #ISTH2026, Paris 🇫🇷 has just been named the most attractive city in the world for the fifth time in a row by @euromonitor.bsky.social in its Top 100 City Destinations Index!🏆 bit.ly/4ozqczL
011
Thomas Reiser @tomreiser.bsky.social · 11/12/2025
💡What are the skills & strategies required to effectively read, critique, & assess research articles? 🖥️Watch the new recorded @ISTH.org, WFH & @eahad.bsky.social webinar specifically designed for haemophilia nurses! 🎙️Speakers:@katekhair.bsky.social 🇬🇧, BJ Ramsay 🇳🇿 bit.ly/4oITNqB
010
Thomas Reiser @tomreiser.bsky.social · 10/12/2025
How do researchers evaluate the effects of andexanet in healthy volunteers & patients with acute major bleeding on enoxaparin? 🗓️Register for the Dec. 18 (17:00 UTC) @ISTH.org @rpth.bsky.social Research Recap w/author Thijs van Haaps 🇳🇱 & Moderator Lara Roberts 🇬🇧 bit.ly/4azaql5
010
Thomas Reiser @tomreiser.bsky.social · 09/12/2025
🚨ICYMI!🚨 Abstract submission for @ISTH.org #ISTH2026 in Paris 🇫🇷 is now OPEN! ✅Showcase your work internationally ✅Gain visibility on a global stage ✅Connect & collaborate w/colleagues ✅Qualify for travel & #ISTHEarlyCareer awards ⏳Deadline: Feb 2, 2026 isthcongress.org/abstracts 🔗
010
Thomas Reiser @tomreiser.bsky.social · 08/12/2025
👏Congrats to the @novonordisk.bsky.social Haemophilia Foundation for becoming the "Novo Nordisk Haemophilia & Haemoglobinopathies Foundation"! Through this expanded support for those affected by sickle cell disease & thalassaemia, @isth.org looks fwd to seeing even more lives improved. nnhf.org
010
Thomas Reiser @tomreiser.bsky.social · 08/12/2025
🚨@ISTH.org Members🚨 ⏰ If your membership expires on December 31, check your email inbox for your renewal reminder! Take advantage of limited-time discounted rates. Secure your membership & stay connected to the global🌍thrombosis & hemostasis community! Renew today! bit.ly/4prbMmz
022
Thomas Reiser @tomreiser.bsky.social · 06/12/2025
What awaits you at the #ISTH2026 Congress & why should you submit abstracts & participate? In the latest @ISTH.org Pulse podcast W. Ageno 🇮🇹 @cihanaymd.bsky.social 🇦🇹 & host @gbarnesmd.bsky.social 🇺🇸 go behind the scenes of the congress preps. 🎧Listen & join the journey to Paris 🇫🇷: bit.ly/48PRg9a
032
Thomas Reiser @tomreiser.bsky.social · 05/12/2025
🚨Join a global learning experience for #ISTHEarlyCareer physicians! 💡The @ISTH.org team-based learning course brings together early career physicians & expert mentors from around the🌐to collaborate on complex bleeding & clotting cases. Learn more & apply by Jan 3: bit.ly/4rSDsTd
010
Thomas Reiser @tomreiser.bsky.social · 04/12/2025
🚨Learn more about the latest accepted #SSC projects for Q1 2026. 💡These initiatives will move the @ISTH.org mission forward by contributing to the broader scientific knowledge of conditions related to #thrombosis and #hemostasis and bringing those findings to clinical practice. bit.ly/4af7ytt
010
Thomas Reiser @tomreiser.bsky.social · 03/12/2025
💡The @isth.org #SSC has been busy - dont miss the latest SSC ✅communications ✅guidance ✅guidelines published in @jthjournal.bsky.social : ℹ️https://bit.ly/4p1GYZz
021
Thomas Reiser @tomreiser.bsky.social · 02/12/2025
🚨 Don't miss tomorrow's @ISTH.org "#SSC on the Case" webinar! 💡 Speakers Michelle Lavin 🇮🇪 , Kathleen Freson 🇧🇪 & moderator Ferdows Atiq 🇬🇧 will discuss basic research & clinical insights into the burden, assessment & etiology of bleeding in von Willebrand's disease 🗓️Dec. 3 / 13:00 UTC bit.ly/4pl1uUx
000
Thomas Reiser @tomreiser.bsky.social · 01/12/2025
🥳The wait is over - Abstract Submission is officially open! Let the journey to Paris 🇫🇷 @ISTH.org #ISTH2026 officially begin. Don't miss the opportunity to showcase your latest research at the largest int'l meeting in #thrombosis & #hemostasis. Start today: bit.ly/48F1w39
011
Thomas Reiser @tomreiser.bsky.social · 29/11/2025
💡What are the challenges & opportunities in expanding access to care, building research capacity, & strengthening global collaboration in #thrombosis & #hemostasis? Listen to the latest @ISTH.org Pulse Podcast w/host🎙️Julia Sandrin Gauer 🇬🇧! & guest Tamrat Assefa Tadesse 🇪🇹 🎧https://bit.ly/4p00yVN
001
Thomas Reiser @tomreiser.bsky.social · 26/11/2025
Congratulations to Dr. Floor Heubel-Moenen at Maastricht UMC 🇳🇱, the @isth.org Claire McLintock Memorial Award on Women’s Health Issues in T+H recipient for her research on “Menstrual Blood Coagulation in Heavy Menstrual Bleeding: Uncovering Local Haemostatic Defects to Improve Diagnosis & Care”
000
Thomas Reiser @tomreiser.bsky.social · 25/11/2025
Don't miss the exciting next @ISTH.org "#SSC on the Case" webinar! Speakers Michelle Lavin 🇮🇪 , Kathleen Freson 🇧🇪 & moderator Ferdows Atiq 🇬🇧 will discuss the burden, assessment & etiology of bleeding in von Willebrand's disease 🗓️December 3 at 13:00 UTC Register now & plan to attend: bit.ly/4pl1uUx
010
Thomas Reiser @tomreiser.bsky.social · 24/11/2025
Check out the latest @jthjournal.bsky.social "JTH in Clinic" article providing clinicians w/real-world tools to manage gynecologic bleeding in patients on anticoagulation. Published in collab w/the Found. for Women & Girls w/Blood Disorders, it offers assess. & treatment guidance, bit.ly/4oOoD1N
021
Thomas Reiser @tomreiser.bsky.social · 23/11/2025
The Pulse - The @ISTH.org monthly newsletter is now on LinkedIn! Subscribe to get notified and never miss the latest Society information, news, reminders, scientific & educational updates, deadlines, meetings, awards and more! bit.ly/4r1Gy6K
010
Thomas Reiser @tomreiser.bsky.social · 22/11/2025
Happy Saturday! For some weekend listening, tune into the latest @ISTH.org Pulse Podcast episode. Host Julia Sandrin Gauer & guests May Anne Cheong & @joythitac.bsky.social discuss 'Amplifying Science: Social Media, Publishing & the Power of Connection' 🎧http://bit.ly/4r4tI7X
020
Thomas Reiser @tomreiser.bsky.social · 19/11/2025
🚨Applications for the @ISTH.org Council elections are now open! Lead and shape the future of the global #thrombosis and #hemostasis field! Nominate yourself or encourage a colleague to apply. Learn more about responsibilities, eligibility & criteria: bit.ly/4nWhJXc
000
Thomas Reiser @tomreiser.bsky.social · 18/11/2025
🚨New @ISTH.org CME activity available: "Rebalancing Therapies for #Hemophilia: Are You Ready?" Gain the latest insights on emerging rebalancing treatments, compare evolving clinical profiles & learn how to prepare your team for what's next in #hemophilia care: bit.ly/3Lwg6C9
000
Thomas Reiser @tomreiser.bsky.social · 17/11/2025
🚨Available now in @ISTH.org @rpth.bsky.social ✅First illustrated review on #Hemophilia B by @cedrichermans.bsky.social et al. Discover HemB's biological complexity, therapeutic progress, ongoing challenges & exciting perspectives ahead through visuals in an innovative format.
bit.ly
Haemophilia B: an illustrative review of current challenges and opportunities
Hemophilia B is a genetic bleeding disorder caused by a deficiency of clotting factor IX, which presents unique challenges in clinical management. Advances in therapeutic strategies for hemophilia B…
000
Thomas Reiser @tomreiser.bsky.social · 16/11/2025
Congratulations to @isth.org Councilor @middeldorps.bsky.social on being named & delivering the 2025 Sol Sherry Disting. Lecture in Thrombosis @ the recent @americanheart.bsky.social Scientific Sessions recognizing her role as a foremost clinician & researcher in the field of CV disease & stroke!
141
Thomas Reiser @tomreiser.bsky.social · 15/11/2025
Can #AI keep up with #thrombosis specialists🤔? In the latest @ISTH.org Pulse Podcast episode guest @nikola-vladic.bsky.social & host @gbarnesmd.bsky.social dive into the data, incl. how AI stacked up against experts in patient education & clinical decision-making 🎧http://bit.ly/3X9FMH4
011
Thomas Reiser @tomreiser.bsky.social · 10/11/2025
💡Save the date for the next @isth.org career development webinar with tips from global experts and renowned teachers and mentors how to be a better educator: 🎙@julierayes.bsky.social 🇬🇧 🎙Stephan Moll 🇺🇸 🎙️Nicola Potere 🇨🇦 🗓️November 19 14:00 UTC bit.ly/4mQOGUv
011
Thomas Reiser @tomreiser.bsky.social · 06/11/2025
Join the🗓️Nov. 13 @ISTH.org webinar on the role of viscoelastic testing in fibrinolytic disorders Speakers P. Collins 🇬🇧 & J. Brogaard Larsen 🇩🇰 discuss evaluating fibrinolysis through viscoelastic testing & provide a clinical applications focusing on acute obstetric coagulopathy. tinyurl.com/3dfakhk9
011
Thomas Reiser @tomreiser.bsky.social · 03/11/2025
⏱️The road to Paris 🇫🇷 begins now! Get ready to submit your science to the @ISTH.org #ISTH2026 Congress and be part of the global conversation shaping the future of #thrombosis & #hemostasis. Abstract submissions open Dec. 1 & deadline is Feb. 2. isthcongress.org/abstracts
011
Thomas Reiser @tomreiser.bsky.social · 31/10/2025
🆕 Browse a curated collection of the best recorded sessions from the #ISTH2025 Congress. The Education Committee selected the top content to watch for free for all @ISTH.org Core Members (pay options available for ISTH Academy and non-Members). Sign in & watch now! tinyurl.com/2h2ee6ce
023
Thomas Reiser @tomreiser.bsky.social · 28/10/2025
The @isth.org Guidance and Guidelines Committee invites public review and comment on the guidance manuscript "Management of anticoagulation in patients with heparin-induced thrombocytopenia requiring cardiac surgery with cardiopulmonary bypass" tinyurl.com/5n6t28yp
tinyurl.com
Public Comment: Anticoagulation in HIT req Cardiac Surgery
011
Thomas Reiser @tomreiser.bsky.social · 27/10/2025
Don't miss the next @isth.org #SSC on the Case" webinar discussing #hemophilia in women and girls. Register now and join Moderator Munira Borhany 🇵🇰 and Speakers: Lakshmi Srivaths 🇺🇸 Samantha Pasca 🇮🇹 on 📅 November 3, 2025 17:00 PM UTC tinyurl.com/28tk445e
000
Thomas Reiser @tomreiser.bsky.social · 25/10/2025
For your weekend listening, check out the latest @ISTH.org Pulse Podcast episode. Host Julia Sandrin Gauer talks w/Renee Zhao how groundbreaking research from Stanford University could transform thrombectomy success rates & improve outcomes for patients w/blood clots. 🎧: bit.ly/4qlLYsL
000
Thomas Reiser @tomreiser.bsky.social · 24/10/2025
ICYMI earlier this week - now available as a recording: @ISTH.org @rpth.bsky.social Research Recap: Activated prothrombin complex concentrate in patients receiving emicizumab prophylaxis w/ Robert Sidonio, Cedric Hermans, @profmakris.bsky.social
youtube.com
RPTH Research Recap: Activated PCC in patients receiving emicizumab prophylaxis
Join us for this exciting webinar on the recent RPTH article: "Activated prothrombin complex concentrate in patients receiving emicizumab prophylaxis: from evidence to clinical practice." Join Author…
000
Thomas Reiser @tomreiser.bsky.social · 18/10/2025
Tune into the latest episode of the @ISTH.org Pulse Podcast! Moderator @gbarnesmd.bsky.social & speakers Victor Tapson & Andrew Niekamp explore how mechanical thrombectomy is transforming the treatment landscape for #VTE. 📺 bit.ly/4qjLBze 🎧 bit.ly/4qcJJYH #WTDay25
021
Thomas Reiser @tomreiser.bsky.social · 17/10/2025
The @ISTH.org Guidelines & Guidance Committee invites public comments on the guidance manuscript, "Development of New Antithrombotic Drugs for Children (Part 1): Guidance from the #SSC Subcomm. on Ped. & Neonatal T & H and the Pedi-ATLAS Group" 🗓️Oct. 30
tinyurl.com
Public Comment: Pediatric Antithrombotic Trials Guidance
Public Comment: Pediatric Antithrombotic Trials Guidance.
010
Thomas Reiser @tomreiser.bsky.social · 15/10/2025
Thank you for your support & participation in the #WorldThrombosisDay "Head to Toe" campaign. This year, we've educated millions that blood clots can occur anywhere in the circulatory system. Because of you, lives have been changed & even saved! #awareness #WTDay25 @worldthrombosisday.bsky.social
031
Thomas Reiser @tomreiser.bsky.social · 14/10/2025
🚨 Nominate your mentor heroes for the 3rd annual @isth.org Outstanding Mentor Awards! This award recognizes individuals who have demonstrated an ongoing commitment to cultivate & mentor early career professionals, positively impacting their mentees’ careers. Learn more & nominate▶️ bit.ly/42zqcI2
011
Thomas Reiser @tomreiser.bsky.social · 13/10/2025
🚨Just in time for today's @worldthrombosisday.bsky.social, congratulations to the #WTDay25 global advocacy award winners. 🎇🎆 🏆The Awards honor individuals and organizations from around the world who are making a difference in blood clot awareness. Learn more ⬇️https://bit.ly/3W15Nb4
021
Thomas Reiser @tomreiser.bsky.social · 13/10/2025
Today is #WorldThrombosisDay! Help us raise awareness about blood clots & save lives. ✅Share your story ✅educate your community ✅spread the word about thrombosis prevention. ⁠ ⁠Every action counts - be part of the change! @worldthrombosisday.bsky.social worldthrombosisday.org⁠ #WTDay25
031
Thomas Reiser @tomreiser.bsky.social · 12/10/2025
🚨Tomorrow is #WorldThrombosisDay🚨 🎧to the latest @isth.org Pulse Podcast w/Lai Heng Lee 🇸🇬 & @bhwords.bsky.social 🇬🇧 as they share global insights on hospital-associated #VTE prevention, highlight gaps in care, & explore opport. for improvement #WTDay25 @worldthrombosisday.bsky.social bit.ly/46WJjhT
042
Thomas Reiser @tomreiser.bsky.social · 10/10/2025
Don't miss this @ISTH.org @rpth.bsky.social Research Recap on: "Activated prothrombin complex concentrate in patients receiving emicizumab prophylaxis: from evidence to clinical practice." 📅 October 21, 15:15 UTC 🎙️Robert Sidonio, Cedric Hermans & @profmakris.bsky.social bit.ly/4hbAYKE
020
Thomas Reiser @tomreiser.bsky.social · 09/10/2025
⏰Pre-register for a pre-recorded @worldthrombosisday.bsky.social webinar on #thrombophilia screening & its appropriate use in global #thrombosis care w/speakers 🎙️Lana Castellucci 🇨🇦 🎙️@cihanaymd.bsky.social 🇦🇹 Registrants will receive the webinar via email on Oct. 12. bit.ly/3KGSeLu #WTDay25
021
Thomas Reiser @tomreiser.bsky.social · 08/10/2025
📢HCPs - Use your voice for something that matters! 💡Take part in @isth.org #WorldThrombosisDay on 🗓️October 13 #WTDay25 @worldthrombosisday.bsky.social No excuses, we make it easy for you ⬇️ Head to Toe Awareness: 30 Ways to Make an Impact This World Thrombosis Day
bit.ly
Head to Toe Awareness: 30 Ways to Make an Impact This World Thrombosis Day
Prepare for World Thrombosis Day 2025 with powerful strategies to engage your community in the "From Head to Toe, Take Control" campaign. Community engagement amplifies thrombosis awareness, making…
022
Thomas Reiser @tomreiser.bsky.social · 07/10/2025
Your expertise is requested! Improve future #guidance with this survey on the role of Immune modulation in Antiphospholipid Syndrome (APS). Results will be used to focus future studies and shape guidance documents from the @isth.org #SSC Subcommittee on APS. bit.ly/489LH5P
021